Serum neurofilament light protein as a biomarker in Niemann-Pick disease, type C1. [PDF]
Cawley NX +11 more
europepmc +1 more source
Evaluation of the Genetic Background of Patients with Niemann-Pick Disease. [PDF]
Alipouran F +2 more
europepmc +1 more source
Comparison of neonatal systemic and intracerebroventricular AAV9 gene therapy delivery demonstrating improved behavioral and phenotypic outcomes in a mouse model of Niemann-Pick disease, type C1. [PDF]
Epstein BE +6 more
europepmc +1 more source
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease [PDF]
et al,, Jiang, Xuntian, Ory, Daniel S
core +1 more source
Arimoclomol and levacetylleucine for the treatment of neurologic manifestations of Niemann-Pick disease type C: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). [PDF]
Rodriguez-Gil JL +4 more
europepmc +1 more source
Clinical characteristics and treatment outcomes in patients with Niemann-Pick disease type C (NP-C): a cross-sectional study. [PDF]
Karimzadeh P +7 more
europepmc +1 more source
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway [version 1; referees: 2 approved, 2 approved with reservations] [PDF]
et al,, Ory, Daniel S
core +1 more source
Gene Expression Profile of the Cerebral Cortex of Niemann-Pick Disease Type C Mutant Mice. [PDF]
Servín-Muñoz IV +5 more
europepmc +1 more source
[Niemann-Pick disease with two missense mutations in SMPD1 gene: a case report and literature review]. [PDF]
Wei Y, Guo H, Xu JN, Chen YY, Shi HX.
europepmc +1 more source
Implications of the choroid plexus in Niemann-Pick disease Type C neuropathogenesis. [PDF]
van Gool R +18 more
europepmc +1 more source

